Lipoprotein(a) and cardiovascular disease: Evidence, recommendations and emerging therapies
Lipoprotein(a) (Lp[a]) is a low-density lipoprotein (LDL) like particle which has atherogenic, proinflammatory and prothrombotic properties. Elevated in approximately 1 in 5 persons, increased levels of Lp(a) have been shown by epidemiological, genome wide association studies and Mendelian randomisa...
Saved in:
| Main Author: | Wong Nathan D. |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medical Society of the Republic of Srpska, Banja Luka, University of Banja Luka. Faculty of Medicine
2025-01-01
|
| Series: | Scripta Medica |
| Subjects: | |
| Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/2490-3329/2025/2490-33292502343W.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lipoprotein(a): Assessing the Current Knowledge and Gaps in Screening and Treatment—A Narrative Review
by: Octavian Amaritei, et al.
Published: (2025-04-01) -
The heterogeneity of lipoproteins and their role in the development of cardiovascular diseases
by: E. A. Utkina, et al.
Published: (2019-06-01) -
Lipoprotein(a), atherosclerosis and cardiovascular risk
by: E. A. Polyakova, et al.
Published: (2024-12-01) -
Role of Lipoprotein(a) in Atherosclerotic Cardiovascular Disease in South Asian Individuals
by: Darshan Patel, et al.
Published: (2025-07-01) -
LIPOPROTEIN APHERESIS: YESTERDAY, TODAY, TOMORROW. REVIEW
by: U. Julius, et al.
Published: (2018-09-01)